Litigation Details for Bionpharma Inc. v. Corerx, Inc. (S.D.N.Y. 2021)
✉ Email this page to a colleague
Bionpharma Inc. v. Corerx, Inc. (S.D.N.Y. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-12-13 |
| Court | District Court, S.D. New York | Date Terminated | 2023-05-15 |
| Cause | 28:1332 Diversity Action | Assigned To | John George Koeltl |
| Jury Demand | None | Referred To | Valerie Figueredo |
| Patents | 10,039,745; 10,154,987; 6,011,068; 9,669,008; 9,808,442 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Bionpharma Inc. v. Corerx, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Bionpharma Inc. v. Corerx, Inc. (S.D.N.Y. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-02-02 | 69 | Declaration in Support of Motion | of Azurity’s Epaned® patents (U.S. Patent Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,868… (D. Del.) (regarding the ’008, ’442, and ’745 Patents); Silvergate Pharm. Inc. v. Bionpharma …-1067-LPS (D. Del.) (regarding the ’987 Patent). Case 1:21-cv-10656-JGK Document 69 Filed… Del.) (regarding the ’008, ’442, and ’745 Patents); Silvergate Pharm. Inc. v. Bionpharma Inc.…. No. 19-1067-LPS (D. Del.) (regarding the ’987 Patent). 4. Attached hereto as Exhibit 3 is a true and | External link to document |
| 2022-02-02 | 75 | Declaration in Support of Motion | Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,868, 10,786,482, 10,799,476, 10,918,621, 11,040,023…several patents directed to stable oral liquid formulations of enalapril. These include U.S. Patent Nos.…Bionpharma for patent infringement by its generic drug product of several of the patents I identified …identified above. Later, after additional patents issued, Azurity brought additional suits for Bionpharma’s infringement…infringement of the newly obtained patents. Litigation concerning Bionpharma’s infringement is ongoing | External link to document |
| 2022-02-11 | 90 | Declaration in Support of Motion | Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,868, 10,786,482, 10,799,476, 10,918,621, 11,040,023…several patents directed to stable oral liquid formulations of enalapril. These include U.S. Patent Nos.…Bionpharma for patent infringement by its generic drug product of several of the patents I identified …identified above. Later, after additional patents issued, Azurity brought additional suits for Bionpharma’s infringement…infringement of the newly obtained patents. Litigation concerning Bionpharma’s infringement is ongoing | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
